Endothelial cell-specific molecule 1 (ESM-1), also known as endocan, is a biomarker for endothelial dysfunction [103] and may serve as a novel evaluation method for risk stratification of patients with acute STEMI [104]. Here, ESM1 is linked to endothelial dysfunction.